Mark Miller, MD
Sleep Medicine · Olney, MDNPI 1659306439
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,017 of the $1,367 with a category attached, or 74.4%. It is spread thinly across 21 manufacturers, the largest accounting for just 18.3%. 2025 is the largest year on record at $670, more than ten times the $53 reported in 2019.
Across 45 payments — averaging $30.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avadel CNS Pharmaceuticals, LLC$251
- Jazz Pharmaceuticals Inc.$210
- Astellas Pharma US Inc$198
- Inspire Medical Systems, Inc.$140
- Harmony Biosciences LLC$126
- Lilly USA, LLC$65
- plus $376 from 15 others
What the payments were for
- Consulting fees$35026%
- Food & beverage$1,01774%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 4 | $251 |
| Jazz Pharmaceuticals Inc. | 4 | $210 |
| Astellas Pharma US Inc | 6 | $198 |
| Inspire Medical Systems, Inc. | 4 | $140 |
| Harmony Biosciences LLC | 6 | $126 |
| Lilly USA, LLC | 3 | $65 |
| Amgen | 2 | $46 |
| Merck | 2 | $41 |
| Johnson & Johnson | 2 | $37 |
| ZOLL Respicardia, Inc. | 1 | $30 |
| Aerin Medical Inc. | 1 | $28 |
| Boston Scientific | 1 | $25 |
| Abbott | 1 | $24 |
| Novo Nordisk | 1 | $23 |
| Atricure, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| AstraZeneca | 1 | $15 |
| 3b Medical, Inc. | 1 | $12 |
| Resmed Corp | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,367 in reported general payments places this provider in the 60th percentile of 41 sleep medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 25 | $506 |
| Trazodone Hcl | 16 | $332 |
| Clonazepam | 17 | $113 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Olney
- Syed AhmedGermantown$75K
- Asefa MekonnenRockville$28K
- Pamela HowardRockville$14K
- Konrad BakkerFrederick$8K
- Amandeep BawaBaltimore$7K
- Stephanie WappelTowson$4K
- Talar KachechianRockville$4K
- Catherine GriffinBaltimore$3K
- Kanaiyalal PatelGreenbelt$3K
- Nabil AltememiChevy Chase$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.